U8, Piano: II, Stanza: 2,6 Via Cadore, 48 - 20900 MONZA
Pubblicazioni
Scheggi, S., Guzzi, F., Braccagni, G., De Montis, M., Parenti, M., & Gambarana, C. (2020). Targeting PPARα in the rat valproic acid model of autism: focus on social motivational impairment and sex-related differences. MOLECULAR AUTISM, 11(1), 62-78.Dettaglio
Capra, V., Accomazzo, M., Rovati, G., Capra, V., Mauri, M., Guzzi, F., et al. (2017). Impaired thromboxane receptor dimerization reduces signaling efficiency: A potential mechanism for reduced platelet function in vivo. BIOCHEMICAL PHARMACOLOGY, 124, 43-56.Dettaglio
Ripamonti, S., Ambrozkiewicz, M., Guzzi, F., Gravati, M., Biella, G., Bormuth, I., et al. (2017). Transient oxytocin signaling primes the development and function of excitatory hippocampal neurons. ELIFE, 6.Dettaglio
Fanelli, F., Mauri, M., Capra, V., Raimondo, F., Guzzi, F., Ambrosio, M., et al. (2011). Light on the structure of thromboxane A2 receptor heterodimers. CELLULAR AND MOLECULAR LIFE SCIENCES, 68(18), 3109-3120.Dettaglio
Innamorati, G., Giannone, F., Guzzi, F., Rovati, G.E., Accomazzo, M.R., Chini, B., et al. (2009). Heterotrimeric G proteins demonstrate differential sensitivity to beta-arrestin dependent desensitization. CELLULAR SIGNALLING, 21(7), 1135-1142.Dettaglio